Infinitus Launched AI Suite for Pharma Sales Teams

Pharma field teams can now automate reimbursement inquiries and CRM updates using new AI agents.

Updated on Oct. 7, 2026 in Healthcare

A leather medical folder sits on a clean, modern clinical desk in a sterile, bright medical office.
Infinitus has introduced FieldForce, a new suite of AI agents designed to automate administrative tasks and reimbursement inquiries for pharmaceutical field sales representatives. AI Illustration. Upload story photo >

Live Poll

Do you trust artificial intelligence to handle professional communications and relationship management on your behalf?

Infinitus has launched FieldForce, a suite of AI agents designed to assist pharmaceutical sales representatives and field reimbursement managers. These tools provide 24/7 support for navigating prior authorization and reimbursement requirements.

Why it matters

The product addresses the growing operational strain on pharmaceutical field teams, which must now manage larger provider territories with stagnant or shrinking personnel budgets.

The FieldForce suite provides 24/7 inbound call support for pharmaceutical reimbursement tasks, contrasting with traditional staffing models that typically operate within standard business hours.

The players

Infinitus

A health-technology company that provides AI-driven automation tools for pharmaceutical commercial operations and reimbursement processes.

The details

FieldForce agents integrate directly with existing customer relationship management systems to automate administrative tasks and meeting preparation. By leveraging a proprietary dynamic knowledge graph and organization-specific data, the system answers complex questions regarding claims and prior authorization processes.

Timeline

  1. October 7, 2026: Infinitus announced the launch of the FieldForce product suite.

Market Landscape

This launch represents a direct technological intervention into the industry-wide trend of pharmaceutical field teams managing expanding provider territories with limited staffing. It follows a shift toward automated commercial operations intended to offload repetitive inquiry management.

Operators in pharmaceutical sales should assess whether current reimbursement workflows are a primary bottleneck preventing more frequent provider interactions. Evaluate if automating administrative CRM tasks can feasibly increase the total provider count covered by existing personnel.

The takeaway

AI-driven commercial operations allow firms to scale support without proportional headcount increases. Managers should track the ratio of administrative time spent on prior authorizations versus actual provider engagement to determine if these AI agents offer a clear return on investment.

Further reading

For broader trends in medical administration, explore the Healthcare section.

Live Poll

Do you trust artificial intelligence to handle professional communications and relationship management on your behalf?